HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Does routine prophylactic oral flucloxacillin reduce the incidence of post-circumcision infections?

AbstractBACKGROUND:
Cost-effective and safe practices are required for the scale-up of medical male circumcision (MMC), a strategy recommended for biomedical HIV prevention.
METHODS:
A retrospective medical record review was conducted of post-circumcision wound infection incidence at a massive MMC program in Soweto, South Africa. We compared patients who received routine 250 mg prophylactic flucloxacillin 4 times daily orally for 5 days with those who did not receive prophylaxis. Patients with HIV infection and those with missing prophylaxis data were excluded from the analysis. Collated data included prophylaxis received, age, return for follow-up, and presence and grading of wound infection at follow-up.
RESULTS:
In total, 1,291 patients were eligible: 646 flucloxacillin recipients and 645 non-recipients. Median age of flucloxacillin recipients was 24 years (interquartile range 20-29 years) and for nonrecipients it was 23 years (interquartile range 16-28 years). Eighty-one percent of flucloxacillin recipients and 87% of nonrecipients (P = .0019) returned for follow-up. Wound infection was present in 0.7% (5 of 646) of flucloxacillin recipients and 1.2% (8 of 645) of non-recipients (P = .4). Use of routine prophylactic flucloxacillin did not significantly reduce incidence of post-MMC wound infection (odds ratio, 0.6; 95% confidence interval, 0-1.2).
CONCLUSIONS:
When compared with no prophylactic flucloxacillin, routine prophylactic flucloxacillin does not significantly reduce the risk of post-MMC wound infection in a massive circumcision program.
AuthorsLimakatso Lebina, Fatima Laher, Hillary Mukudu, Thandekile Essien, Kennedy Otwombe, Glenda Gray, Neil Martinson
JournalAmerican journal of infection control (Am J Infect Control) Vol. 41 Issue 10 Pg. 897-900 (Oct 2013) ISSN: 1527-3296 [Electronic] United States
PMID23489735 (Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2013 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.
Chemical References
  • Anti-Bacterial Agents
  • Floxacillin
Topics
  • Administration, Oral
  • Adolescent
  • Adult
  • Anti-Bacterial Agents (administration & dosage)
  • Circumcision, Male (adverse effects)
  • Floxacillin (administration & dosage)
  • Humans
  • Incidence
  • Male
  • Retrospective Studies
  • South Africa (epidemiology)
  • Surgical Wound Infection (epidemiology, prevention & control)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: